MabCure, Inc. (MBCI)

Market Cap	156.22K -96.1%
Revenue (ttm)	500.00K
Net Income	-12.26M
EPS	-0.19
Shares Out	781.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,640
Average Volume	58,497
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0000 - 0.0003
Beta	12.38
RSI	60.90
Earnings Date	n/a

About MabCure

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains...

• Industry: Solar
• Sector: Technology
• Founded: 2006
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: MBCI